Cover Image

Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury

The clinical outcome of spinal cord injury (SCI) depends in part on the extent of secondary damage, to which apoptosis contributes. The CD95 and tumor necrosis factor (TNF) ligand/receptor systems play an essential role in various apoptotic mechanisms. To determine the involvement of these ligands i...

Full description

Saved in:
Bibliographic Details
Main Authors: Demjen, Deana (Author) , Kleber, Susanne (Author) , Zuliani, Cecilia (Author) , Stieltjes, Bram (Author) , Walczak, Henning (Author) , Essig, Marco (Author) , Edler, Lutz (Author) , Krammer, Peter H. (Author) , Martín-Villalba, Ana (Author)
Format: Article (Journal)
Language:English
Published: 7 March 2004
In: Nature medicine
Year: 2004, Volume: 10, Issue: 4, Pages: 389-395
ISSN:1546-170X
DOI:10.1038/nm1007
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/nm1007
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/nm1007
Get full text
Author Notes:Deana Demjen, Stefan Klussmann, Susanne Kleber, Cecilia Zuliani, Bram Stieltjes, Corinna Metzger, Ulrich A. Hirt, Henning Walczak, Werner Falk, Marco Essig, Lutz Edler, Peter H. Krammer & Ana Martin-Villalba
Description
Summary:The clinical outcome of spinal cord injury (SCI) depends in part on the extent of secondary damage, to which apoptosis contributes. The CD95 and tumor necrosis factor (TNF) ligand/receptor systems play an essential role in various apoptotic mechanisms. To determine the involvement of these ligands in SCI-induced damage, we neutralized the activity of CD95 ligand (CD95L) and/or TNF in spinal cord-injured mice. Therapeutic neutralization of CD95L, but not of TNF, significantly decreased apoptotic cell death after SCI. Mice treated with CD95L-specific antibodies were capable of initiating active hind-limb movements several weeks after injury. The improvement in locomotor performance was mirrored by an increase in regenerating fibers and upregulation of growth-associated protein-43 (GAP-43). Thus, neutralization of CD95L promoted axonal regeneration and functional improvement in injured adult animals. This therapeutic strategy may constitute a potent future treatment for human spinal injury.
Item Description:Gesehen am 06.04.2021
Physical Description:Online Resource
ISSN:1546-170X
DOI:10.1038/nm1007

Similar Items